Join Free
My Account
Log in
Join Free
Log in

ResMed and CSL shares are cheap & Tesla’s cyber truck is coming to Australia?

Will Ozempic sink ResMed Inc (ASX:RMD) and CSL Limited (ASX:CSL)? Will Tesla's Cyber Truck come to Australia? The Australian Investors Podcast explains...

Listen on:

Apple Podcasts
Spotify
YouTube

Listen now

About this episode

Will Ozempic sink ResMed Inc (ASX: RMD) and CSL Limited (ASX: CSL)? Will Tesla’s Cyber Truck come to Australia?

Your Australian Investors Podcast 2 Sense hosts, Owen Rask and Drew Meredith, tackle your questions on topics like:

  • Drew and Owen’s #1 piece of advice for peeps in their 20s, 40s and 60s
  • With war on the horizon, how do investors deal with uncertainty in the financial markets?
  • Netflix’s results
  • How new investors can identify growth companies
  • Offset or shares: should I pay down debt or buy shares?
  • Fixed income or offset account: are bonds worth it?

What is ResMed?

ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.

Episode resources

Podcast series resources

If you like this episode, you’ll LOVE our series. Episodes go live every Saturday at 7 am and Wednesday arvo.

We air an interview with an Australian or international investing expert every Wednesday, and Q&A every Saturday! Subscribe below.

Got a question you want answered on the podcast?

Ask a question
Sponsored by:
global x advert for the FANG+ ETF
FANG ETF global X advert, square
  • CSL Limited (ASX:CSL), Resmed CDI (ASX:RMD), Vanguard Australian Shares Index ETF (ASX:VAS)
  • Netflix Inc (NASDAQ:NFLX), Tesla Inc (NASDAQ:TSLA)
  • Vanguard Australian Shares Index ETF (ASX:VAS)

Share this episode:

Facebook
X
LinkedIn
Email
WhatsApp

Information warning: The information on this website and in our podcasts is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.

Latest episodes

All Episodes

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Skip to content